Overview

Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
In the context of australian general practice, to determine the efficacy and safety of ezetimibe 10mg/statin 40mg coadministration in patients with uncontrolled cholesterol receiving statin 40mg or more.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe